Vacuum-Assisted Abdominal Closure Is Safe and Effective: A Cohort Study in 74 Consecutive Patients

R O Jensen; T Buchbjerg; R M Simonsen; R Eckardt; N Qvist

doi:10.1155/2017/7845963

Vacuum-Assisted Abdominal Closure Is Safe and Effective: A Cohort Study in 74 Consecutive Patients

R O Jensen, T Buchbjerg, R M Simonsen, R Eckardt, N Qvist

Odense University Hospital

Research output: Contribution to journal › Journal article › Research › peer-review

187 Downloads (Pure)

Abstract

BACKGROUND: Vacuum-assisted closure (VAC) has, in many instances, become the treatment of choice in patients with abdominal catastrophes. This study describes the use and outcome of ABThera KCI® VAC in the Region Southern Denmark covering a population of approximately 1.202 mill inhabitants.

METHOD: A prospective multicenter study including all patients treated with VAC during an eleven-month period.

RESULTS: A total of 74 consecutive patients were included. Median age was 64.4 (9-89) years, 64% were men, and median body mass index was 25 (17-42). Duration of VAC treatment was median 4.5 (0-39) days with median 1 (0-16) dressing changes. Seventy per cent of the patients attended the intensive care unit. The 90-day mortality was 15%. A secondary closure of the fascia was obtained in 84% of the surviving patients. Only one patient developed an enteroatmospheric fistula. Patients with secondary closure were less likely to develop large hernias and had better self-evaluated physical health score (p < 0,05). No difference in mental health was found.

CONCLUSION: The abdominal VAC treatment in patients with abdominal catastrophes is safe and with a relative low complication rate. Whether it might be superior to conventional treatment with primary closure when possible has yet to be proven in a randomized study.

Original language	English
Article number	7845963
Journal	Surgery Research and Practice
Volume	2017
Number of pages	5
ISSN	2356-7759
DOIs	https://doi.org/10.1155/2017/7845963
Publication status	Published - 2017

Keywords

Journal Article

Documents & Links

10.1155/2017/7845963Licence: CC BY

Vacuum-Assisted Abdominal Closure Is Safe and EffectiveFinal published version, 1.31 MBLicence: CC BY

Cite this

@article{98a02e5d683d4c269e843e27c2ecb44a,

title = "Vacuum-Assisted Abdominal Closure Is Safe and Effective: A Cohort Study in 74 Consecutive Patients",

abstract = "BACKGROUND: Vacuum-assisted closure (VAC) has, in many instances, become the treatment of choice in patients with abdominal catastrophes. This study describes the use and outcome of ABThera KCI{\textregistered} VAC in the Region Southern Denmark covering a population of approximately 1.202 mill inhabitants.METHOD: A prospective multicenter study including all patients treated with VAC during an eleven-month period.RESULTS: A total of 74 consecutive patients were included. Median age was 64.4 (9-89) years, 64% were men, and median body mass index was 25 (17-42). Duration of VAC treatment was median 4.5 (0-39) days with median 1 (0-16) dressing changes. Seventy per cent of the patients attended the intensive care unit. The 90-day mortality was 15%. A secondary closure of the fascia was obtained in 84% of the surviving patients. Only one patient developed an enteroatmospheric fistula. Patients with secondary closure were less likely to develop large hernias and had better self-evaluated physical health score (p < 0,05). No difference in mental health was found.CONCLUSION: The abdominal VAC treatment in patients with abdominal catastrophes is safe and with a relative low complication rate. Whether it might be superior to conventional treatment with primary closure when possible has yet to be proven in a randomized study.",

keywords = "Journal Article",

author = "Jensen, {R O} and T Buchbjerg and Simonsen, {R M} and R Eckardt and N Qvist",

year = "2017",

doi = "10.1155/2017/7845963",

language = "English",

volume = "2017",

journal = "Surgery Research and Practice",

issn = "2356-7759",

publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Vacuum-Assisted Abdominal Closure Is Safe and Effective

T2 - A Cohort Study in 74 Consecutive Patients

AU - Jensen, R O

AU - Buchbjerg, T

AU - Simonsen, R M

AU - Eckardt, R

AU - Qvist, N

PY - 2017

Y1 - 2017

N2 - BACKGROUND: Vacuum-assisted closure (VAC) has, in many instances, become the treatment of choice in patients with abdominal catastrophes. This study describes the use and outcome of ABThera KCI® VAC in the Region Southern Denmark covering a population of approximately 1.202 mill inhabitants.METHOD: A prospective multicenter study including all patients treated with VAC during an eleven-month period.RESULTS: A total of 74 consecutive patients were included. Median age was 64.4 (9-89) years, 64% were men, and median body mass index was 25 (17-42). Duration of VAC treatment was median 4.5 (0-39) days with median 1 (0-16) dressing changes. Seventy per cent of the patients attended the intensive care unit. The 90-day mortality was 15%. A secondary closure of the fascia was obtained in 84% of the surviving patients. Only one patient developed an enteroatmospheric fistula. Patients with secondary closure were less likely to develop large hernias and had better self-evaluated physical health score (p < 0,05). No difference in mental health was found.CONCLUSION: The abdominal VAC treatment in patients with abdominal catastrophes is safe and with a relative low complication rate. Whether it might be superior to conventional treatment with primary closure when possible has yet to be proven in a randomized study.

AB - BACKGROUND: Vacuum-assisted closure (VAC) has, in many instances, become the treatment of choice in patients with abdominal catastrophes. This study describes the use and outcome of ABThera KCI® VAC in the Region Southern Denmark covering a population of approximately 1.202 mill inhabitants.METHOD: A prospective multicenter study including all patients treated with VAC during an eleven-month period.RESULTS: A total of 74 consecutive patients were included. Median age was 64.4 (9-89) years, 64% were men, and median body mass index was 25 (17-42). Duration of VAC treatment was median 4.5 (0-39) days with median 1 (0-16) dressing changes. Seventy per cent of the patients attended the intensive care unit. The 90-day mortality was 15%. A secondary closure of the fascia was obtained in 84% of the surviving patients. Only one patient developed an enteroatmospheric fistula. Patients with secondary closure were less likely to develop large hernias and had better self-evaluated physical health score (p < 0,05). No difference in mental health was found.CONCLUSION: The abdominal VAC treatment in patients with abdominal catastrophes is safe and with a relative low complication rate. Whether it might be superior to conventional treatment with primary closure when possible has yet to be proven in a randomized study.

KW - Journal Article

U2 - 10.1155/2017/7845963

DO - 10.1155/2017/7845963

M3 - Journal article

C2 - 29085880

SN - 2356-7759

VL - 2017

JO - Surgery Research and Practice

JF - Surgery Research and Practice

M1 - 7845963

ER -

Vacuum-Assisted Abdominal Closure Is Safe and Effective: A Cohort Study in 74 Consecutive Patients

Abstract

Keywords

Documents & Links

Fingerprint

Cite this